Last reviewed · How we verify

NCT05223075

Articaine Versus Lidocaine Buccal Infiltration

Status unknown Phase 2 Last updated 15 February 2023
What this trial tests

Phase 2 trial testing articaine local anethesia with vasoconstrictor in Pain in 31 participants. Status unknown.

Timeline
11 November 2022
Primary endpoint
28 February 2023
2 March 2023

Quick facts

Lead sponsorFayoum University
PhasePhase 2
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment31
Start date11 November 2022
Primary completion28 February 2023
Estimated completion2 March 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Fayoum University

Who can join

18 and older, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

assess the effect of articaine versus lidocaine in only buccal infiltration of local anethesia in lower anterior teeth

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Articaine versus Lidocaine in only buccal infiltration anesthesia for the extraction of mandibular anterior teeth. A prospective split-mouth randomized-controlled clinical study.
    Al-Mahalawy H, El-Mahallawy Y, Abdelrahman HH, Refahee SM. · · 2023 · cited 3× · PMID 37641122 · DOI 10.1186/s12903-023-03292-5

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Fayoum University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05223075.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing